INGREZZA
Live / Applied — Non-final action mailed (as of 17 Jan 2026)
What this means for you
Not registered yet, but its 26 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99358616
- Mark type
- Design + words
- Filed
- 26 Aug 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease
- Class 044 — Medical, beauty and agricultural services: Providing medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 17 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 17 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 17 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jan 2026 — NON-FINAL ACTION E-MAILED
- 17 Jan 2026 — NON-FINAL ACTION WRITTEN
- 15 Jan 2026 — ASSIGNED TO EXAMINER
- 14 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 14 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Aug 2025 — NEW APPLICATION ENTERED